| pubmed-article:19151145 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19151145 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
| pubmed-article:19151145 | lifeskim:mentions | umls-concept:C0403529 | lld:lifeskim |
| pubmed-article:19151145 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
| pubmed-article:19151145 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:19151145 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
| pubmed-article:19151145 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:19151145 | pubmed:dateCreated | 2009-5-21 | lld:pubmed |
| pubmed-article:19151145 | pubmed:abstractText | Although the clinical importance of demonstrating the presence of anti-glomerular basement membrane (anti-GBM) antibodies is well established, less is known concerning the clinical utility of measuring the levels of autoantibodies. Two conformational epitopes of anti-GBM antibodies have been defined at residues 17-31 and 127-141 of the alpha3(IV)NC1 domain of type IV collagen [alpha3(IV)NC1], which were named as EA and EB, respectively. In order to elucidate the importance of such antibodies, we studied the levels and the epitope specificities of anti-GBM antibodies in a large cohort of Chinese patients with anti-GBM disease. | lld:pubmed |
| pubmed-article:19151145 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19151145 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19151145 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19151145 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19151145 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19151145 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19151145 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19151145 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19151145 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19151145 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19151145 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19151145 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19151145 | pubmed:issn | 1460-2385 | lld:pubmed |
| pubmed-article:19151145 | pubmed:author | pubmed-author:WangHai-YanHY | lld:pubmed |
| pubmed-article:19151145 | pubmed:author | pubmed-author:ZhaoJuanJ | lld:pubmed |
| pubmed-article:19151145 | pubmed:author | pubmed-author:HellmarkThoma... | lld:pubmed |
| pubmed-article:19151145 | pubmed:author | pubmed-author:YangRuiR | lld:pubmed |
| pubmed-article:19151145 | pubmed:author | pubmed-author:ZhaoMing-HuiM... | lld:pubmed |
| pubmed-article:19151145 | pubmed:author | pubmed-author:CuiZhaoZ | lld:pubmed |
| pubmed-article:19151145 | pubmed:author | pubmed-author:SegelmarkMart... | lld:pubmed |
| pubmed-article:19151145 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19151145 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:19151145 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19151145 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19151145 | pubmed:pagination | 1838-44 | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:meshHeading | pubmed-meshheading:19151145... | lld:pubmed |
| pubmed-article:19151145 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19151145 | pubmed:articleTitle | Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. | lld:pubmed |
| pubmed-article:19151145 | pubmed:affiliation | Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University and Key Laboratory of Renal disease, Ministry of Health of China, Beijing 100034, People's Republic of China. | lld:pubmed |
| pubmed-article:19151145 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19151145 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
